Diabetes Drugs May Impact Cancer Growth

Scientists are studying how common diabetes drugs like metformin, SGLT2 inhibitors, and GLP-1 receptor agonists might affect cancer.

These drugs are usually used to control blood sugar and body weight, but researchers are now looking at how they might also change how cancer cells grow and spread.

The study found that these drugs can influence the immune system, inflammation, and even how cancer cells multiply.

For example, metformin might help slow down tumor growth and strengthen the body's ability to fight cancer.

However, the effects are not the same for all types of cancer, and more research is needed to fully understand these connections.

This is important because it could help doctors use these diabetes drugs in new ways to prevent or treat cancer in the future.